Pom Doctor operates an online medical platform in China specializing in chronic disease management, primarily for hepatological and andrological conditions. The company facilitates digital follow-up consultations and prescription renewals for patients who have already established relationships with doctors offline. Patients connect with their existing providers via a mobile app or WeChat to receive ongoing care without visiting a hospital. Pom Doctor operates two integrated segments: an Internet Hospital and a Pharmaceutical Supply Chain. The Internet Hospital handles consultations and generates prescriptions, while the supply chain fulfills those orders and provides wholesale distribution to third-party pharmacies and wholesalers. The company generates revenue through direct drug sales to patients and wholesale pharmaceutical distribution. This model leverages the recurring nature of chronic disease treatment to drive high patient retention and predictable purchase behavior. As platform volume increases, Pom Doctor uses its scale to negotiate favorable procurement terms from drug suppliers. The company's growth strategy includes expanding into additional medical departments, integrating with government medical insurance systems to reduce patient out-of-pocket costs, and developing AI-enabled tools and smart wearable devices to create a closed-loop disease management system.